$GNSZ News

GenSpera executes funding 10:30 a.m. May 29, 2014 - Seeking Alpha
10-Q: GENSPERA INC 5:08 p.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: GENSPERA INC 7:08 a.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: GENSPERA INC 3:37 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)

GenSpera CEO, Craig Dionne, to Present Update on Lead Drug Candidate G-202 at 2014 Bio International Convention 8:00 a.m. Today - PR Newswire - PRF
GenSpera Announces $3.33 Million Registered Public Offering 8:54 a.m. May 29, 2014 - BusinessWire - BZX
IPOs and Transactions: March 17 - 21 12:30 p.m. March 24, 2014 - PR Newswire - PRF
First Patient Enrolled in GenSpera G-202 Phase II Glioblastoma Trial 8:03 a.m. March 18, 2014 - BusinessWire - BZX
GenSpera CEO, Craig Dionne, to Present at BIO CEO & Investor Conference, February 10th 10:02 a.m. Feb. 6, 2014 - BusinessWire - BZX
GenSpera CEO to Present at New York Society of Security Analysts' Life Sciences Conference 8:02 a.m. Oct. 28, 2013 - BusinessWire
Final Phase I Data on GenSpera's G-202 Presented at Symposium on Molecular Targets and Cancer Therapeutics 8:02 a.m. Oct. 22, 2013 - BusinessWire
GenSpera G-202 Principal Investigator Presents Phase I Data at Symposium on Molecular Targets and Cancer Therapeutics 8:02 a.m. Oct. 17, 2013 - BusinessWire
GenSpera Receives Patent on Targeted Prostate Cancer Drugs 8:02 a.m. June 6, 2013 - BusinessWire